← Leaderboards
Kevin R Lynch
University Of Virginia
$18,485,029
Attributed
$23,394,430
Total exposure
11
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,394,430 · 11
By mechanism
R01$14,345,376 · 7
T32$8,196,775 · 2
R21$852,279 · 2
Top collaborators
- Webster L Santos15 shared
- Michelle L Bland3 shared
- Thurl E. Harris3 shared
- Mitchell H. Rosner2 shared
- Gilbert R Kinsey1 shared
- Rahul Sharma1 shared
Most similar at University Of Virginia
Same institution · by research overlap
- Karen K Hirschi$27,264,013
- Bradley David Gelfand$8,956,117
- J. Julius Zhu$9,689,433
- Swapnil K. Sonkusare$13,409,275
- Richard J Price$15,866,868
Others in their field
Top investigators on “Pharmacology”
- Leonard Freedman · Leidos Biomedical Research, Inc.$244,272,171
- Constance Ann Benson · University Of California, San Diego$243,271,751
- Daniel R Kuritzkes · Brigham And Women'S Hospital$211,464,839
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$173,041,343
- Garret A Fitzgerald · University Of Pennsylvania$142,571,551
- David Heimbrook · Leidos Biomedical Research, Inc.$130,037,760
Research focus
PharmacologyBiologySphingosine 1-PhosphateBlood VesselsPharmaceutical PreparationsIn VivoPropertySignal TransductionDoseProgramsLymphocyteSphingosine KinaseBloodPlasmaEdg-1 ProteinLeadCellsScienceTrainingInhibitor/AntagonistMultiple SclerosisLipidsAgonistDisease Model
Grant awards (66)
Blockade of S1P pathway for renal fibrosis therapy$572,063
R01 · FY2025 · DK
Training in the Pharmacological Sciences$373,815
T32 · FY2025 · GM · contact PI
Blockade of S1P pathway for renal fibrosis therapy$616,104
R01 · FY2024 · DK
Training in the Pharmacological Sciences$329,616
T32 · FY2024 · GM · contact PI
Controlling the flux of sphingosine-1-phosphate in vivo$689,462
R01 · FY2023 · AI · contact PI
Training in the Pharmacological Sciences$265,268
T32 · FY2023 · GM · contact PI
Controlling the flux of sphingosine-1-phosphate in vivo$689,462
R01 · FY2022 · AI · contact PI
Training in the Pharmacological Sciences$364,252
T32 · FY2022 · GM · contact PI
Controlling the flux of sphingosine-1-phosphate in vivo$689,462
R01 · FY2021 · AI · contact PI
Training in the Pharmacological Sciences$341,340
T32 · FY2021 · GM · contact PI
Controlling the flux of sphingosine-1-phosphate in vivo$689,812
R01 · FY2020 · AI · contact PI
Training in the Pharmacological Sciences$337,439
T32 · FY2020 · GM · contact PI
MD-PHAR Controlling sphingosine 1-phosphate synthesis and trafficking$90,940
R01 · FY2020 · GM · contact PI
Controlling the flux of sphingosine-1-phosphate in vivo$720,889
R01 · FY2019 · AI · contact PI
Controlling sphingosine 1-phosphate synthesis and trafficking$448,536
R01 · FY2019 · GM · contact PI
Training in the Pharmacological Sciences$333,629
T32 · FY2019 · GM · contact PI
Controlling sphingosine 1-phosphate synthesis and trafficking$527,689
R01 · FY2018 · GM · contact PI
Training in the Pharmacological Sciences$329,909
T32 · FY2018 · GM · contact PI
Circulating Renal-Protective Mediators in Cardiac Surgery Patients$201,875
R21 · FY2018 · DK
Controlling sphingosine 1-phosphate synthesis and trafficking$527,689
R01 · FY2017 · GM · contact PI
Training in the Pharmacological Sciences$311,470
T32 · FY2017 · GM · contact PI
Circulating Renal-Protective Mediators in Cardiac Surgery Patients$241,500
R21 · FY2017 · DK
Controlling sphingosine 1-phosphate synthesis and trafficking$542,189
R01 · FY2016 · GM · contact PI
Training in the Pharmacological Sciences$322,743
T32 · FY2016 · GM · contact PI
In Vivo Probes of Sphingosine Kinase Function$368,198
R01 · FY2015 · GM
Training in the Pharmacological Sciences$319,295
T32 · FY2015 · GM · contact PI
In Vivo Probes of Sphingosine Kinase Function$374,885
R01 · FY2014 · GM
Molecular Pharmacology of Sphingosine 1-Phosphate$357,078
R01 · FY2014 · GM · contact PI
Training in the Pharmacological Sciences$315,939
T32 · FY2014 · GM · contact PI
In Vivo Probes of Sphingosine Kinase Function$388,656
R01 · FY2013 · GM
Molecular Pharmacology of Sphingosine 1-Phosphate$364,580
R01 · FY2013 · GM · contact PI
Training in the Pharmacological Sciences$312,582
T32 · FY2013 · GM · contact PI
Mitochondrial Lipid Kinase$217,848
R21 · FY2013 · HD · contact PI
Molecular Pharmacology of Sphingosine 1-Phosphate$357,078
R01 · FY2012 · GM · contact PI
Training in the Pharmacological Sciences$236,722
T32 · FY2012 · GM · contact PI
Mitochondrial Lipid Kinase$191,056
R21 · FY2012 · HD · contact PI
Molecular Pharmacology of Sphingosine 1-Phosphate$357,078
R01 · FY2011 · GM · contact PI
Training in the Pharmacological Sciences$286,356
T32 · FY2011 · GM · contact PI
Molecular Pharmacology of Sphingosine 1-Phosphate$326,304
R01 · FY2010 · GM · contact PI
Training in the Pharmacological Sciences$283,181
T32 · FY2010 · GM · contact PI
Molecular Pharmacology of Sphingosine 1-Phosphate$329,707
R01 · FY2009 · GM · contact PI
Training in the Pharmacological Sciences$281,639
T32 · FY2009 · GM · contact PI
Molecular Pharmacology of Sphingosine 1-Phosphate$329,812
R01 · FY2008 · GM · contact PI
Training in the Pharmacological Sciences$280,096
T32 · FY2008 · GM · contact PI
Molecular Pharmacology of Sphingosine 1-Phosphate$329,914
R01 · FY2007 · GM · contact PI
Training in the Pharmacological Sciences$314,397
T32 · FY2007 · GM · contact PI
Training in the Pharmacological Sciences$360,322
T32 · FY2006 · GM · contact PI
Molecular Pharmacology of Lysophosphatidic Acid$330,137
R01 · FY2006 · GM · contact PI
Molecular Pharmacology of Sphingosine 1-Phosphate$310,714
R01 · FY2006 · GM · contact PI
Training in the Pharmacological Sciences$360,322
T32 · FY2005 · GM
Molecular Pharmacology of Lysophosphatidic Acid$338,171
R01 · FY2005 · GM
Molecular Pharmacology of Sphingosine 1-Phosphate$317,677
R01 · FY2005 · GM
Training in the Pharmacological Sciences$360,322
T32 · FY2004 · GM
Molecular Pharmacology of Lysophosphatidic Acid$338,256
R01 · FY2004 · GM
Molecular Pharmacology of Sphingosine 1-Phosphate$304,058
R01 · FY2004 · GM
LYSOPHOSPHATIDIC ACID AND THE PROGRESSION OF PROSTATE CA$198,856
R01 · FY2004 · CA
Training in the Pharmacological Sciences$352,507
T32 · FY2003 · GM
Molecular Pharmacology of Lysophosphatidic Acid$325,091
R01 · FY2003 · GM
LYSOPHOSPHATIDIC ACID AND THE PROGRESSION OF PROSTATE CA$198,883
R01 · FY2003 · CA
TRAINING IN THE PHARMACOLOGICAL SCIENCES$262,349
T32 · FY2002 · GM
LYSOPHOSPHATIDIC ACID AND THE PROGRESSION OF PROSTATE CA$191,480
R01 · FY2002 · CA
MOLECULAR PHARMACOLOGY OF LYSOPHOSPHATIDIC ACID$310,582
R01 · FY2001 · GM
TRAINING IN THE PHARMACOLOGICAL SCIENCES$287,631
T32 · FY2001 · GM
LYSOPHOSPHATIDIC ACID AND THE PROGRESSION OF PROSTATE CA$192,348
R01 · FY2001 · CA
MOLECULAR PHARMACOLOGY OF LYSOPHOSPHATIDIC ACID$301,536
R01 · FY2000 · GM
TRAINING IN THE PHARMACOLOGICAL SCIENCES$273,634
T32 · FY2000 · GM